Primary record
N-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide
- 库存
- 719 克
- 纯度
- 99.7 %
- CAS
- 1339928-25-4
化合物标识与属性
- CAS
- 1339928-25-4
- PubChem CID
- 54575456
- SMILES
- CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO
- Canonical SMILES
- COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1
名称与同义词
- Fimepinostat
- CUDC-907
- 1339928-25-4
- fimepinostatum
- PI3K/HDAC Inhibitor
- CUDC907
- CUDC 907
- Fimepinostat [USAN]
- PI3K/HDAC Inhibitor centn
- RefChem:599212
- 3S9RX35S5X
- UNII-3S9RX35S5X
- Fimepinostat (USAN/INN)
- FIMEPINOSTAT [INN]
- D0E6UZ
- Fimepinostat (CUDC-907)
- MFCD22420823
- CHEMBL3622533
- C23H24N8O4S
- MLS006010994
- FIMEPINOSTAT [WHO-DD]
- DTXSID90712307
- GTPL8952
- orb1306535
- SCHEMBL1284705
- SCHEMBL29353052
- SCHEMBL29493089
- KS-00000TDO
- AOB6775
- DTXCID00663053
- EX-A742
- JOWXJLIFIIOYMS-UHFFFAOYSA-N
- GLXC-05006
- HMS3656H04
- HMS3673E03
- PI3K/HDAC INHIBITOR CUDC-907
- BCP06870
- 2341AH
- ABP001045
- BDBM50188961
- EBC-11476
- NSC771751
- s2759
- ZINC73488511
- AKOS026750340
- CCG-269763
- CS-1610
- CUDC-907 (PI3K/HDAC InhibitorI)
- DB11891
- NSC-771751
- SB16569
- CUDC-907 (PI3K/HDAC InhibitorI)?
- NCGC00346692-01
- NCGC00346692-04
- NCGC00346692-11
- AC-30227
- AK199731
- AS-57131
- BC600514
- BP-40068
- CID:54575456
- DA-34958
- HY-13522
- QC-11642
- SMR004702794
- SY242159
- CUDC-907, 98% - 5MG 5mg
- SID:522924662
- DB-057451
- N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
- A4097
- FT-0700168
- NS00072982
- SW219871-1
- J3.695.618F
- N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide
- A11153
- D11319
- Z-3251
- A887983
- C576940
- BRD-K77638923-001-02-0
- Q27076926
- 1339928-25-4 , C23H24N8O4S , CUDC907 , CUDC 907
- 2-[[2-(6-methoxy-3-pyridyl)-4-morpholino-thieno[3,2-d]pyrimidin-6-yl]methyl-methyl-amino]pyrimidine-5-carbohydroxamic acid
- 5-PYRIMIDINECARBOXAMIDE, N-HYDROXY-2-(((2-(6-METHOXY-3-PYRIDINYL)-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)METHYLAMINO)-
- N-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide
- N-Hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-5-pyrimidinecarboxamide
- N-Hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide
- 5-pyrimidinecarboxamide, N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-
- N-HYDROXY-2-(((2-(6-METHOXYPYRIDIN-3-YL)-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)(METHYL)AMINO)PYRIMIDINE-5-CARBOXAMIDE
- N-hydroxy-2-((2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno(3,2-d)pyrimidin-6-yl)methyl-methylamino)pyrimidine-5-carboxamide
- N-Hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-morpholinothieno[3,2-d]pyrimidine-6-yl]methyl]methylamino]pyrimidine-5-carboxamide
- N-Hydroxy-2-[[[2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl]methyl](methyl)amino]pyrimidine-5-carboxamide